Helius Medical Technologies Inc reports results for the quarter ended June 30 - Earnings Summary

• Helius Medical Technologies Inc HSDT reported a quarterly adjusted loss of $79.73​​ per share for the quarter ended June 30, higher than the same quarter last year, when the company reported EPS of $-480.00. The lone analyst forecast for the quarter was for a loss of $128.50 per share.

• Revenue fell 76.4% to $43.00 thousand from a year ago; analysts expected $75.00 thousand.

• Helius Medical Technologies Inc's reported EPS for the quarter was a loss of $79.73​.

• The company reported a quarterly loss of $9.83 million.

• Helius Medical Technologies Inc shares had fallen by 33.8% this quarter and lost 98.8% so far this year.

FORECAST CHANGES

• The mean earnings estimate of analysts had fallen by about 0.8% in the last three months.​

• In the last 30 days, there have been no earnings estimate revisions by analysts covering the company.

RECOMMENDATIONS

• The current average analyst rating on the shares is "hold" and the breakdown of recommendations is no "strong buy" or "buy," 1 "hold" and no "sell" or "strong sell." The average consensus recommendation for the advanced medical equipment & technology peer group is "buy."

This summary was machine generated from LSEG data August 15 at 05:24 p.m. UTC. ​All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)